Cardiac MRI has established and emerging roles in the diagnosis, risk stratification, and management of hypertrophic cardiomyopathy.
Supports cardiac MRI in HCM pathways; extends synthesis while leaving optimal use of emerging applications open.
Hypertrophic cardiomyopathy (HCM) is a genetic disease characterized by abnormal myocardial hypertrophy, which can lead to a wide clinical spectrum, including sudden cardiac death and heart failure. Cardiac MRI has a significant role in establishing the diagnosis of HCM. In the three principal management issues related to HCM; testing of family members of affected individuals; assessing the risk of sudden cardiac death from lethal ventricular arrhythmias; and selection of appropriate treatments for left ventricular outflow obstruction, cardiac MRI has established or emerging roles.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: